The World Health Organization (WHO) is a specialised agency of the United Nations (UN) based in Geneva. It is the UN's coordinating authority on international public health.
- We are actively involved in discussions on public health and on protecting intellectual property, e.g. for improved access to drugs
- We are committed to ensuring intellectual property has a good reputation as an incentive, in particular in relation to the development and therefore the availability of new drugs
- We advise the Swiss delegation, which is led by the Federal Office of Public Health (FOPH)
- We also play an active role in negotiating the relevant resolutions
A working group of the Swiss government (co-led by the IPI) published an Overview on the implementation and contribution of Swiss actors (pdf) in May 2011 on the WHO's Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property.
21.09.2018 | Law and policy
Information event on the revised Patents Act for experts and practitioners
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève
Patents and pharmaceuticals - Public event at the IPI in collaboration with the European Patent Office